SG
UPC icon

StoneX Group’s Universe Pharmaceuticals Inc UPC Stock Holding History

StoneX Group’s Portfolio UPC Stock Details UPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25
Closed -$3.66K – 919
2024
Q3 		$3.66K Buy
+25
New +$42.5K ﹤0.01% 353

Other funds holding UPC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

StoneX Group's UPC Position: Q4 2024 in Review

StoneX Group sold out of Universe Pharmaceuticals Inc (UPC) in Q4 2024, closing a stake of 25 shares — an estimated $3.66K sold.

StoneX Group first reported a position in UPC in Q3 2024 and held it in 1 quarter. The position peaked at $3.66K in Q3 2024. 3 funds tracked by Wall St. Rank hold UPC as of Q4 2024.

  • StoneX Group reported no remaining Universe Pharmaceuticals Inc position as of Q4 2024 after selling out during the quarter.
  • StoneX Group sold 25 Universe Pharmaceuticals Inc shares in Q4 2024, an estimated $3.66K.
  • StoneX Group first reported a position in Universe Pharmaceuticals Inc in Q3 2024 and held it in 1 quarter.
  • StoneX Group's Universe Pharmaceuticals Inc position peaked at $3.66K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q4 2024.

Based on StoneX Group's 13F filing for Q4 2024, filed 12 Feb 2025.